Braham Jmili N, Nsaibia S, Jacob M C, Omri H, Laatiri M A, Yacoub S, Braham Y, Aouni M, Kortas M
Faculty of Pharmacy, University of Center, Monastir, Tunisia.
Clin Lab Sci. 2009 Fall;22(4):208-15.
The aims of this flow cytometry study were to quantify B lymphoid precursors known as hématogones across age and clinical conditions and to study the immunophenotypic profile of these benign immature B cells. A total of 406 consecutive marrow specimens were analyzed for hématogones using 4-color flow cytometry during a 19 month period (60% males and 40% females). The age range was 3 months to 89 years. Hématogones were present in 80% of the specimens. Morphologic analysis of the smears from each patient showed small numbers of hématogones (<13% of total cellularity). The B cell population was defined by CD19 + CD45 bright positivity, coexpression of other B lineage markers: CD20, CD22, CD10, CD29, CD38 and CD58 in addition to HLA-DR and CD34. In our study we found a significant decline in hématogones with increasing age but a broad range was found at all ages. Marrow from some adults contained relatively high numbers. Diagnosis in these patients included cytopenias, infections, and neoplastic diseases. Distinction of hématogones is critical for disease management particularly after therapy of paediatric B acute lymphoblastic leukaemia to monitor for minimal residual disease.
这项流式细胞术研究的目的是量化不同年龄和临床状况下被称为造血母细胞的B淋巴样前体细胞,并研究这些良性未成熟B细胞的免疫表型特征。在19个月的时间里,共对406份连续的骨髓标本进行了分析,采用四色流式细胞术检测造血母细胞(男性占60%,女性占40%)。年龄范围为3个月至89岁。80%的标本中存在造血母细胞。对每位患者涂片的形态学分析显示造血母细胞数量较少(占总细胞数的<13%)。B细胞群体通过CD19 + CD45强阳性来定义,除了HLA-DR和CD34外,还共表达其他B系标志物:CD20、CD22、CD10、CD29、CD38和CD58。在我们的研究中,我们发现造血母细胞数量随着年龄的增长显著下降,但在所有年龄段都有较宽的范围。一些成年人的骨髓中含有相对较高数量的造血母细胞。这些患者的诊断包括血细胞减少、感染和肿瘤性疾病。区分造血母细胞对于疾病管理至关重要,尤其是在小儿B急性淋巴细胞白血病治疗后监测微小残留病时。